SynAbs is proud to announce strategic deal with successful company Singapore Advanced Biologics.
https://www.synabs.be/2017/10/24/synabs-inks-first-distribution-agreement-in-asia/
SABio is a Singapore-based producer and distributor of custom biologics such as RNA oligos, secondary antibodies, transfection reagents and peptides. SYnAbs monoclonal antibodies catalogue, composed of unique rat and guinea pig secondary mAbs, is perfectly complementary to SABio's mouse monoclonal antibodies expertise.
Under the terms of the agreement, SABio will have access to unique portfolio of rats and guinea pigs mAbs to address Singapore territories needs in R&D and IVD fields.
Choonjoo Kho - Chief Executive Officer SABio
Innovation Centre Block 1, Unit 103,
16 Nanyang Drive, Singapore 637722
RSS